Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Feb;7(Suppl 1):S46-S48.
doi: 10.21037/tlcr.2018.01.07.

Tumor heterogenicity: multiple needle biopsies from different lesion sites-key to successful targeted therapy and immunotherapy

Affiliations
Editorial

Tumor heterogenicity: multiple needle biopsies from different lesion sites-key to successful targeted therapy and immunotherapy

Paul Zarogoulidis et al. Transl Lung Cancer Res. 2018 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

References

    1. Rodriguez-Antona C, Taron M. Pharmacogenomic biomarkers for personalized cancer treatment. J Intern Med 2015;277:201-17. 10.1111/joim.12321 - DOI - PubMed
    1. Wildey G, Chen Y, Lent I, et al. Pharmacogenomic approach to identify drug sensitivity in small-cell lung cancer. PLoS One 2014;9:e106784. 10.1371/journal.pone.0106784 - DOI - PMC - PubMed
    1. Lehman JM, Gwin ME, Massion PP. Immunotherapy and Targeted Therapy for Small Cell Lung Cancer: There Is Hope. Curr Oncol Rep 2017;19:49. 10.1007/s11912-017-0609-2 - DOI - PubMed
    1. Domvri K, Zarogoulidis P, Darwiche K, et al. Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy. J Cancer 2013;4:736-54. 10.7150/jca.7734 - DOI - PMC - PubMed
    1. Absenger G, Terzic J, Bezan A. ASCO update: lung cancer. Memo 2017;10:224-7. 10.1007/s12254-017-0373-x - DOI - PMC - PubMed

Publication types

LinkOut - more resources